Insights & Intel: The Bracken Blog

David Krause MD FACP Joins Consulting Team

Written by Bracken | Jul 31, 2024 1:59:05 PM

For Immediate Release: NEWTOWN, PA, 31 July 2024 — The Bracken Group (Bracken) is pleased to announce that David Krause MD, FACP is joining the Consulting team as a Senior Partner. With expertise in Medical Affairs, pharmacogenetics, executive leadership, vaccine development, and pharmaceutical R&D, Dr. Krause advances the breadth and depth of Bracken’s wide range of expertise.

David Krause MD, FACP

Dr. Krause is board-certified in internal medicine with added qualifications in geriatrics. Dr. Krause has more than 30 years of experience in pharmaceutical research and development and medical affairs. He has successfully led clinical development and medical affairs teams at large and medium-sized public entities and small private start-ups. He successfully filed multiple BLAs and NDAs. Dr. Krause led clinical development of several global therapeutic areas at SmithKline Beecham and GlaxoSmithKline. He was then Chief Medical Officer at Vicuron Pharmaceuticals, which was later acquired by Pfizer, Inc. Most recently he served as Chief Medical Officer at Genomind, Inc., a private, venture-funded pharmacogenetic testing and medication management company. In addition to clinical development and medical affairs, his expertise includes business development.

Dr. Krause is a Fellow of the American College of Physicians, and author of dozens of scientific publications and numerous abstracts. He has served as a consultant to the Department of Defense and is a member of Genomind’s Scientific Advisory Board.

Dr. Krause is a graduate of the Pennsylvania State University, where he received BAs in Art History and Psychology. He was also named a Centennial Fellow by the College of Liberal Arts. He received his MD degree from Temple University, where he completed his residency in internal medicine.

In his spare time Dr. Krause is a landscape photographer. 

“I’m thrilled to welcome Dr. David Krause to Bracken’s Consulting team,” said Colin G. Miller, PhD, FIPEM, CSci, CEO of Bracken. Dr. Miller went on to say, “With over 30 years of experience in pharmaceutical research and development and medical affairs, David’s leadership experience and medical knowledge are invaluable for Brackens clients. Dr. David Krause's addition solidifies Bracken's standing as the leading clinical development consulting team.”

About Bracken

Bracken offers consulting, regulatory, analytics, marketing, and sales enablement solutions for the life sciences and digital health industries. Through highly experienced consultative support, business programs, and data-enabled products, Bracken provides a multidisciplinary approach to exceeding goals for their clients.

Contact us today to learn more about our services and working directly with Dr. David Krause, as well as Bracken’s full team of expert consultants. Website: www.thebrackengroup.com.